MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$1,657,250K
Marketable debt securities
$1,251,234K
Accounts receivable, net
$777,567K
Prepaid expenses and
other current assets
$281,892K
Inventory
$82,719K
Total current assets
$4,050,662K
Property, plant and
equipment, net
$513,147K
Operating lease
right-of-use assets
$194,916K
Deferred tax assets
$125,975K
Other assets
$59,461K
Restricted investments
$22,170K
Total assets
$4,966,331K
Total liabilities and
stockholders' equity
$4,966,331K
Total liabilities
$4,177,155K
Total stockholders'
equity
$789,176K
Accumulated deficit
-$6,702,524K
Accumulated other
comprehensive loss
-$20,097K
Liabilities related to the
sale of future...
$1,470,341K
Total current
liabilities
$1,466,349K
Convertible debt
$1,007,784K
Operating lease
liabilities, net of current...
$225,087K
Other liabilities
$7,594K
Additional paid-in capital
$7,510,473K
Common stock, 0.01 par
value per share,...
$1,324K
Accrued expenses
$1,080,197K
Liabilities related to the
sale of future...
$220,068K
Accounts payable
$115,721K
Operating lease
liabilities
$45,518K
Deferred revenue
$4,845K
Back
Back
Balance Sheet
source: myfinsight.com
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)